Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status

Normalization of fluorodeoxyglucose positron emission tomography (FDG PET) imaging prior to high-dose therapy and autologous stem cell transplantation (ASCT) improves outcomes in relapsed and refractory (RR) Hodgkin lymphoma (HL), but many patients refractory to platinum-based salvage regimens are u...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hematol Oncol
Egile Nagusiak: Onishi, Maika, Graf, Solomon A., Holmberg, Leona, Behnia, Sanaz, Shustov, Andrei R., Schiavo, Karen, Philip, Mary, Libby, Edward N., Cassaday, Ryan D., Pagel, John M., Roden, Jennifer E., Maloney, David G., Green, Damian J., Till, Brian G., Press, Oliver W., Smith, Stephen D., Gopal, Ajay K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366342/
https://ncbi.nlm.nih.gov/pubmed/25236531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2166
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak